Neuroone Medical Technologies (NMTC) Free Cash Flow (2010 - 2026)

Neuroone Medical Technologies has disclosed Free Cash Flow across 17 years of filings, most recently posting -$1.4 million for Q1 2026.

• Quarterly Free Cash Flow fell 2205.03% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.6 million (down 52.73% YoY) and the FY2025 annual result came in at -$2.9 million, up 73.78% from the prior year.
• Free Cash Flow advanced to -$1.4 million in Q1 2026, from -$3.2 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $951635.0 in Q3 2022 and bottomed at -$3.8 million in Q4 2023.
• The 5-year median for Free Cash Flow is -$2.7 million (2022), against an average of -$2.2 million.
• Year-over-year, Free Cash Flow surged 146.1% in 2022 and plunged 2205.03% in 2026.
• Neuroone Medical Technologies' Free Cash Flow stood at -$3.5 million in 2022, then slipped by 9.78% to -$3.8 million in 2023, then surged by 104.77% to $183633.0 in 2024, then sank by 1818.97% to -$3.2 million in 2025, then jumped by 56.69% to -$1.4 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$1.4 million, -$3.2 million, and -$1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.